The results of the POISE-3 randomized trial showed that tranexamic acid (TXA) reduces the risk of major bleeding in patients undergoing urological surgery. Štúdia zahŕňala viac ako 1 100 pacientov. In the TXA group, 6.1% of patients had major bleeding. Thus, the use of TXA significantly reduced the incidence of major bleeding in urological surgery. The study was published on MedPage Today.